Pharma Takeovers' Effect on New Jersey Economy 3 comments
-
Font Size:
-
Print
- TweetThis
Pfizer (PFE) takes over Wyeth (WYE), a Madison, New Jersey company. Merck (MRK) takes over Schering-Plough (SGP), a Kenilworth, NJ company.
What happens if Johnson & Johnson (JNJ) takes over Bristol-Myers Squibb, headquartered in New York City with facilities spread out over New Jersey? Wall Street brokers and Money Center banks losing jobs has to some extent been absorbed into the New Jersey economy. Mergers and acquisitions in the pharmaceuticals space could push the state into further economic contraction. I am not saying that New Jersey becomes Michigan or Nevada or California but a manageable problem could get worse.
Disclosure: At the time of this Blog entry Scott Rothbort, his family and or clients of LakeView Asset Management, LLC was long shares of SGP convertible preferred stock --- although positions can change at any time.
Related Articles
|
























This article has 3 comments:
I bet it will raise Atlantic City casino taxes versus reduce them as is being requested by the now mostly bankrupt industry. Further, the state can always increase income, sales and property taxes to pay for the new state jobs.
NJ is very resourceful.
It's quite resilient.
More government, less industry equals depression.
Which is EXACTLY where the rest of the country is heading.
It isn't just banking and housing, they were just the only game in town until last year.
Now, we have NOTHING except government.
At what point do people figure out, if the ONLY jobs are government jobs the government workers will have to pay 100% tax to support their own industry.
Every job in government kills 2 to 3 jobs in private industry.
Let's hope that government workers are charitable (most I know aren't-they are greedy and "entitled"), we will need the free soup.
No one should be shocked by this and more is coming.